Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Part of paid clinical trials in Orange, California.

Sponsor
Gynecologic Oncology Group
Study ID
NCT00002813
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.

Key Dates

Start date
Aug 31, 1997
Status verified
Mar 2008
Primary completion
Oct 31, 2004

Study Design

Enrollment
62 participants (estimated)
Primary purpose
TREATMENT

Locations (9)

FacilityCityStateZIPSite coordinators
Chao Family Comprehensive Cancer CenterOrangeCalifornia92868-
MBCCOP - HawaiiHonoluluHawaii96813-
Johns Hopkins Oncology CenterBaltimoreMaryland21231-
CCOP - Ann Arbor RegionalAnn ArborMichigan48106-
Cancer Center of Albany Medical CenterAlbanyNew York12208-
Comprehensive Cancer Center of Wake Forest University Baptist Medical CenterWinston-SalemNorth Carolina27157-1082-
CCOP - Upstate CarolinaSpartanburgSouth Carolina29303-
Brookview Research, Inc.NashvilleTennessee37203-
University of Texas - MD Anderson Cancer CenterHoustonTexas77030-

Find similar trials in Orange, CA

By condition
Cervical cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Chao Family Comprehensive Cancer Center· Orange, CAMBCCOP - Hawaii· Honolulu, HIJohns Hopkins Oncology Center· Baltimore, MDCCOP - Ann Arbor Regional· Ann Arbor, MICancer Center of Albany Medical Center· Albany, NYComprehensive Cancer Center of Wake Forest University Baptist Medical Center· Winston-Salem, NC

Related Studies